160 related articles for article (PubMed ID: 36367829)
1. Mutations of FH and IDH may induce gliomagenesis by similar mechanisms.
Raghunathan A; Ida CM; Westbroek EM; Gupta S; Jenkins RB; Giannini C; Aldape KD
J Neuropathol Exp Neurol; 2022 Dec; 82(1):99-100. PubMed ID: 36367829
[No Abstract] [Full Text] [Related]
2. Metabolic enzymes as oncogenes or tumor suppressors.
Thompson CB
N Engl J Med; 2009 Feb; 360(8):813-5. PubMed ID: 19228626
[No Abstract] [Full Text] [Related]
3. Perspectives on IDH Mutation in Diffuse Gliomas.
Su YT; Phan FP; Wu J
Trends Cancer; 2018 Sep; 4(9):605-607. PubMed ID: 30149878
[TBL] [Abstract][Full Text] [Related]
4. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
5. Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis.
Ohba S; Hirose Y
Neurol Med Chir (Tokyo); 2016; 56(4):170-9. PubMed ID: 26960449
[TBL] [Abstract][Full Text] [Related]
6. IDH mutation in glioma: new insights and promises for the future.
Turkalp Z; Karamchandani J; Das S
JAMA Neurol; 2014 Oct; 71(10):1319-25. PubMed ID: 25155243
[TBL] [Abstract][Full Text] [Related]
7. Isocitrate dehydrogenase mutation as a therapeutic target in gliomas.
Han CH; Batchelor TT
Chin Clin Oncol; 2017 Jun; 6(3):33. PubMed ID: 28705010
[TBL] [Abstract][Full Text] [Related]
8. Diffuse glioma - Rare homozygous IDH point mutation, is it an oncogenetic mechanism?
Singh A; Gurav M; Dhanavade S; Shetty O; Epari S
Neuropathology; 2017 Dec; 37(6):582-585. PubMed ID: 28782849
[TBL] [Abstract][Full Text] [Related]
9. IDH1 and IDH2 mutations in gliomas.
Cohen AL; Holmen SL; Colman H
Curr Neurol Neurosci Rep; 2013 May; 13(5):345. PubMed ID: 23532369
[TBL] [Abstract][Full Text] [Related]
10. IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.
Zhang C; Moore LM; Li X; Yung WK; Zhang W
Neuro Oncol; 2013 Sep; 15(9):1114-26. PubMed ID: 23877318
[TBL] [Abstract][Full Text] [Related]
11. The role of mutation of metabolism-related genes in genomic hypermethylation.
Waterfall JJ; Killian JK; Meltzer PS
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):16-23. PubMed ID: 25111818
[TBL] [Abstract][Full Text] [Related]
12. Isocitrate dehydrogenase 1 and 2 mutations in gliomas.
Megova M; Drabek J; Koudelakova V; Trojanec R; Kalita O; Hajduch M
J Neurosci Res; 2014 Dec; 92(12):1611-20. PubMed ID: 25078896
[TBL] [Abstract][Full Text] [Related]
13. Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.
Mukasa A; Takayanagi S; Saito K; Shibahara J; Tabei Y; Furuya K; Ide T; Narita Y; Nishikawa R; Ueki K; Saito N
Cancer Sci; 2012 Mar; 103(3):587-92. PubMed ID: 22136423
[TBL] [Abstract][Full Text] [Related]
14. Neuro-oncology: Isocitrate dehydrogenase mutations in low-grade gliomas.
Schiff D; Purow BW
Nat Rev Neurol; 2009 Jun; 5(6):303-4. PubMed ID: 19498431
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of IDH mutations in gliomas.
Ichimura K
Brain Tumor Pathol; 2012 Jul; 29(3):131-9. PubMed ID: 22399191
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.
Tietze A; Choi C; Mickey B; Maher EA; Parm Ulhøi B; Sangill R; Lassen-Ramshad Y; Lukacova S; Østergaard L; von Oettingen G
J Neurosurg; 2018 Feb; 128(2):391-398. PubMed ID: 28298040
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathogenesis of Low-Grade Glioma.
Bready D; Placantonakis DG
Neurosurg Clin N Am; 2019 Jan; 30(1):17-25. PubMed ID: 30470401
[TBL] [Abstract][Full Text] [Related]
18. [IDH mutation on glioma].
Mukasa A
Gan To Kagaku Ryoho; 2011 Jun; 38(6):937-40. PubMed ID: 21751529
[No Abstract] [Full Text] [Related]
19. IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
Chang EK; Smith-Cohn MA; Tamrazi B; Ji J; Krieger M; Holdhoff M; Eberhart CG; Margol AS; Cotter JA
Brain Pathol; 2021 Jul; 31(4):e12959. PubMed ID: 33960568
[TBL] [Abstract][Full Text] [Related]
20. Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.
Miller JJ; Shih HA; Andronesi OC; Cahill DP
Cancer; 2017 Dec; 123(23):4535-4546. PubMed ID: 28980701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]